VNDA
Vanda Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.81
-0.48 ▼ -5.17%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$8.88
+0.07 ▲ +0.75%
| Index | RUT | P/E | - | EPS (ttm) | -3.74 | Insider Own | 8.53% | Shs Outstand | 0.06B | Perf Week | 11.66% |
| Market Cap | 0.52B | Forward P/E | - | EPS next Y | 64.58% | Insider Trans | -6.39% | Shs Float | 0.05B | Perf Month | 18.57% |
| Enterprise Value | 0.27B | PEG | - | EPS next Q | -0.69 | Inst Own | 71.76% | Short Float | 8.04% | Perf Quarter | 30.52% |
| Income | -0.22B | P/S | 2.41 | EPS this Y | 40.21% | Inst Trans | -4.95% | Short Ratio | 1.48 | Perf Half Y | 91.52% |
| Sales | 0.22B | P/B | 1.59 | EPS next 5Y | - | ROA | -38.51% | Short Interest | 4.35M | Perf YTD | -0.11% |
| Book/sh | 5.54 | P/C | 1.97 | EPS past 3/5Y | - | ROE | -50.93% | 52W High | -11.37% ($9.94) | Perf Year | 79.07% |
| Cash/sh | 4.47 | P/FCF | - | Sales past 3/5Y | -5.29% -2.73% | ROIC | -65.96% | 52W Low | 131.28% ($3.81) | Perf 3Y | 41.87% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -1049.63% | Gross Margin | 89.77% | Volatility(W/M) | 9.05% 8.25% | Perf 5Y | -50.81% |
| Dividend TTM | - | EV/Sales | 1.25 | Sales Y/Y TTM | 8.72% | Oper. Margin | -69.95% | ATR (14) | 0.68 | Perf 10Y | 14.42% |
| Dividend Ex-Date | - | Quick Ratio | 2.38 | EPS Q/Q | -2737.29% | Profit Margin | -102.02% | RSI (14) | 57.35 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.39 | Sales Q/Q | 7.58% | SMA20 | 11.57% ($7.9) | Beta | 0.59 | Target Price | $15.5 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2000000 | SMA50 | 13.27% ($7.78) | Rel Volume | 0.54 | Prev Close | $9.29 |
| Employees | 533 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | -145.13% -3.47% | SMA200 | 55.55% ($5.66) | Avg Volume(3M) | 2.93M | Price | $8.81 |
| IPO | 2006/4/12 | Option/Short | Yes/Yes | Trades | 11597 | Volume | 1,588,881 | Change | -5.17% |
뉴스 로딩 중...